Head and Neck Cancers Clinical Trial
Official title:
Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Verified date | December 2023 |
Source | Memorial Sloan Kettering Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
Status | Active, not recruiting |
Enrollment | 1307 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes. - Patients will be entered onto this protocol without preference for any racial or ethnic group. - Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy. - The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded. Exclusion Criteria: - Patients not giving informed consent will be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | Memorial Sloan Kettering Cancer Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Memorial Sloan Kettering Cancer Center | American Cancer Society, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future. | 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00721539 -
Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
|
N/A | |
Recruiting |
NCT00568490 -
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
|
||
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A | |
Completed |
NCT00313027 -
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
|
N/A | |
Completed |
NCT00186433 -
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
|
N/A | |
Recruiting |
NCT02997332 -
Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
|
Phase 1 | |
Completed |
NCT02854358 -
Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia
|
Phase 2 | |
Terminated |
NCT01114256 -
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
|
N/A | |
Terminated |
NCT00965003 -
MRI Laryngeal Imaging With a Surface Coil
|
Early Phase 1 | |
Active, not recruiting |
NCT00490061 -
Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
|
Phase 2 | |
Recruiting |
NCT05122221 -
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
|
Phase 1 | |
Completed |
NCT02045368 -
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
|
Phase 1 | |
Completed |
NCT01908504 -
Adaptive Pet Study
|
N/A | |
Completed |
NCT05648682 -
Comparison of the Effectiveness of Three Different Gargates in Radiotherapy-Associated Oral Mucositis
|
N/A | |
Not yet recruiting |
NCT03394417 -
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
|
N/A | |
Completed |
NCT00230295 -
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
|
N/A | |
Completed |
NCT00610415 -
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
|
N/A | |
Completed |
NCT01664936 -
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
|
||
Completed |
NCT01163487 -
Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
|
Phase 1 | |
Terminated |
NCT01137162 -
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
|
N/A |